Intuitive Surgical, Inc. $ISRG Shares Bought by Braidwell LP

Key Points

• Braidwell LP increased its stake in Intuitive Surgical, Inc. by 16.9%, owning 88,000 shares valued at approximately $43.58 million, making it the firm's 26th largest position.
• Intuitive Surgical reported a net revenue of $2.44 billion for the last quarter, exceeding analyst expectations, with an earnings per share (EPS) of $2.19, up from $1.78 a year prior.
• Analyst consensus rates Intuitive Surgical as a Moderate Buy, with an average price target of $595.95, indicating positive market sentiment toward the stock's future performance.

Braidwell LP increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 88,000 shares of the medical equipment provider's stock after acquiring an additional 12,700 shares during the quarter. Intuitive Surgical comprises 1.5% of Braidwell LP's holdings, making the stock its 26th biggest position. Braidwell LP's holdings in Intuitive Surgical were worth $43,584,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. 1248 Management LLC purchased a new stake in Intuitive Surgical during the 1st quarter worth approximately $30,000. Paloma Partners Management Co purchased a new stake in Intuitive Surgical during the 1st quarter worth approximately $1,430,000. Focus Partners Advisor Solutions LLC grew its position in Intuitive Surgical by 75.8% during the 1st quarter. Focus Partners Advisor Solutions LLC now owns 3,777 shares of the medical equipment provider's stock worth $1,871,000 after purchasing an additional 1,629 shares during the last quarter. First Financial Bankshares Inc grew its position in Intuitive Surgical by 5.4% during the 1st quarter. First Financial Bankshares Inc now owns 6,616 shares of the medical equipment provider's stock worth $3,277,000 after purchasing an additional 336 shares during the last quarter. Finally, One Wealth Capital Management LLC grew its position in Intuitive Surgical by 12.3% during the 1st quarter. One Wealth Capital Management LLC now owns 548 shares of the medical equipment provider's stock worth $271,000 after purchasing an additional 60 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 3.0%

Shares of ISRG stock traded up $13.34 during trading hours on Thursday, hitting $454.52. The company's stock had a trading volume of 3,938,868 shares, compared to its average volume of 2,020,191. The company has a 50 day moving average of $496.93 and a 200 day moving average of $515.29. The stock has a market cap of $162.93 billion, a PE ratio of 63.39, a price-to-earnings-growth ratio of 4.96 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same period in the previous year, the business posted $1.78 EPS. The business's revenue was up 21.4% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,769 shares of company stock worth $21,532,536 in the last three months. Company insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research analyst reports. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Royal Bank Of Canada reissued an "outperform" rating and set a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Zacks Research downgraded shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Truist Financial boosted their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Finally, Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.